U.S. Preventive Services Task Force

The U.S. Preventive Services Task Force has concluded there is not enough evidence to recommend skin cancer screenings by primary care physicians in adolescents and adults without symptoms.

There is not yet enough evidence to adequately assess the benefit-harm balance of screening for skin cancer in asymptomatic adolescents and adults, according to a statement from the U.S. Preventive Services Task Force.

Medical organizations are sounding the alarm after a federal judge ruled that it is unconstitutional to require insurers and health plans to cover preventive services recommended by the U.S. Preventive Services Task Force at no cost.

Colorectal cancer screenings more than doubled for adults aged 45 to 49 years after the U.S. Preventive Services Task Force lowered the recommended age to start screening, a study by Epic Research found.

The U.S. Preventive Services Task Force has released a draft recommendation advocating for individuals who are planning to or could become pregnant to take a daily folic acid supplementation of 0.4 to 0.8 mg to prevent neural tube defects.

The U.S. Preventive Services Task Force still does not recommend serologic screening for genital herpes infection in adults who do not exhibit signs or symptoms, according to a final recommendation statement published in JAMA.

Risk-based strategies for lung cancer screening were more cost-effective than screening based on age and smoking history as recommended by the U.S. Preventive Services Task Force, a recent study found.

The U.S. Preventive Services Task Force has released a draft recommendation stating all pregnant persons should have their BP measured at each prenatal visit to help identify and prevent complications of hypertension disorders.

Over the past year, the U.S. Preventive Services Task Force has released recommendations on screening and preventive treatment for various medical conditions

In October, the U.S. Preventive Services Task Force released a final recommendation advocating for anxiety screening in asymptomatic youth aged 8 to 18 years and major depressive disorder screening in asymptomatic youth aged 12 to 18 years.